Literature DB >> 27649292

Placental Pathology in Relation to Uterine Artery Doppler Findings in Pregnancies with Severe Intrauterine Growth Restriction and Abnormal Umbilical Artery Doppler Changes.

Khrystyna Levytska1, Mary Higgins1, Sarah Keating2, Nir Melamed3, Melissa Walker1, Neil J Sebire4, John C P Kingdom1.   

Abstract

Objectives Current guidelines for diagnosis and management of early-onset intrauterine growth restriction (IUGR) rely on umbilical artery Doppler (UAD), without including uterine artery Doppler (UtAD). We hypothesized that IUGR cases with abnormal UAD but normal UtAD has a different spectrum of placental pathology compared with those with abnormal UtAD. Study Design Retrospective review of pregnancies with sonographic evidence of IUGR and abnormal UAD prior to delivery. Cases with ≥ 1 UtAD record(s) after 18+0 weeks' gestation and placental pathology were included. Cases were stratified according to initial UtAD pulsatility index (PI) values (n = 196): normal (n = 19; PI < 95th centile for gestational age/no notching), intermediate (n = 69; PI ≥ 95th centile/no/unilateral notching) and abnormal (n = 108; PI ≥ 95th centile/bilateral notching). Pregnancy outcomes and placental pathology were compared between groups. Results Women in the normal group delivered later than those in the abnormal group (30.1 ± 3.5 vs. 28.0 ± 3.5 weeks; mean ± standard deviation; p = 0.03). Their placentas exhibited higher rates of chronic intervillositis (15.8 vs. 0.9%; p = 0.01), chorangiosis (15.8 vs. 0.9%; p < 0.0001), and massive perivillous fibrin deposition (21.1 vs. 7.4%; p = 0.05), but had lower rates of uteroplacental vascular insufficiency (26.3 vs. 79.6%; p < 0.0001). Conclusion Approximately 10% of pregnancies with early-onset IUGR and abnormal UAD exhibited normal UtAD waveforms. They delivered later, and their placentas exhibited unusual placental pathologies. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27649292     DOI: 10.1055/s-0036-1592347

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

Review 1.  Low molecular weight heparin for the prevention of severe preeclampsia: where next?

Authors:  Kelsey McLaughlin; Ralph R Scholten; John D Parker; Enrico Ferrazzi; John C P Kingdom
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

2.  Exploring in vivo placental microstructure in healthy and growth-restricted pregnancies through diffusion-weighted magnetic resonance imaging.

Authors:  Nickie Andescavage; Wonsang You; Marni Jacobs; Kushal Kapse; Jessica Quistorff; Dorothy Bulas; Homa Ahmadzia; Alexis Gimovsky; Ahmet Baschat; Catherine Limperopoulos
Journal:  Placenta       Date:  2020-03-06       Impact factor: 3.481

3.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 4.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

5.  Fetal Growth Restriction in Hypertensive vs. Heavy Smoking Women-Placental Pathology, Ultrasound Findings, and Pregnancy Outcomes.

Authors:  Daniel Tairy; Eran Weiner; Michal Kovo; Astar Maloul Zamir; Erika Gandelsman; Michal Levy; Hadas Ganer Herman; Eldar Volpert; Letizia Schreiber; Jacob Bar; Giulia Barda
Journal:  Reprod Sci       Date:  2020-11-02       Impact factor: 3.060

Review 6.  Phenotype-Directed Management of Hypertension in Pregnancy.

Authors:  Kelsey McLaughlin; John W Snelgrove; Laura E Sienas; Thomas R Easterling; John C Kingdom; Catherine M Albright
Journal:  J Am Heart Assoc       Date:  2022-03-14       Impact factor: 6.106

Review 7.  Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better?

Authors:  F Mecacci; L Avagliano; F Lisi; S Clemenza; Caterina Serena; S Vannuccini; M P Rambaldi; S Simeone; S Ottanelli; F Petraglia
Journal:  Reprod Sci       Date:  2020-11-19       Impact factor: 3.060

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.